Developing new treatments for antibiotic-resistant infections
Administrative Core
This study is working on new ways to treat infections that don't respond to regular antibiotics, so patients can have better options for getting better and staying healthy.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Washington University NIH-funded |
| Lab location | 1 site (Saint Louis, United States) |
| Project ID | NIH-11042747 on NIH RePORTER |
What this research studies
This research focuses on addressing the growing problem of antibiotic-resistant bacterial infections, which pose a significant threat to public health. By leveraging a collaborative approach among experts in microbiology, immunology, and medicinal chemistry, the project aims to create innovative therapies that can either treat common infections or enhance the effectiveness of existing antibiotics. The Administrative Core will coordinate the various research efforts to ensure progress towards these goals, ultimately translating basic science into practical solutions for patients. Patients may benefit from new treatment options that are less reliant on traditional antibiotics.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals suffering from antibiotic-resistant bacterial infections or those at high risk for such infections.
Not a fit: Patients with infections that are not caused by antibiotic-resistant bacteria may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapies that effectively combat antibiotic-resistant infections, improving patient outcomes.
How similar studies have performed: Other research has shown promise in developing new strategies to combat antibiotic resistance, indicating that this approach could lead to significant advancements.
Where this research is happening
Saint Louis, United States
- Washington University — Saint Louis, United States (Active)
Researchers
- Principal investigator: Hultgren, Scott J. — Washington University
- Study coordinator: Hultgren, Scott J.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.